TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Biolabs AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
74,861
|
76,824
|
85,711 |
Financial expenses |
121
|
27
|
1 |
Earnings before taxes |
-1,930
|
-969
|
4,391 |
EBITDA |
-975
|
21
|
5,445 |
Total assets |
26,017
|
23,580
|
27,144 |
Current assets |
24,289
|
21,066
|
24,315 |
Current liabilities |
17,232
|
15,556
|
15,175 |
Equity capital |
8,741
|
7,547
|
11,210 |
- share capital |
1,612
|
1,604
|
1,745 |
Employees (average) |
30
|
28
|
25 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.6%
|
32.0%
|
41.3% |
Turnover per employee |
2,495
|
2,744
|
3,428 |
Profit as a percentage of turnover |
-2.6%
|
-1.3%
|
5.1% |
Return on assets (ROA) |
-7.0%
|
-4.0%
|
16.2% |
Current ratio |
141.0%
|
135.4%
|
160.2% |
Return on equity (ROE) |
-22.1%
|
-12.8%
|
39.2% |
Change turnover |
-2,359
|
-1,944
|
-11,931 |
Change turnover % |
-3%
|
-2%
|
-12% |
Chg. No. of employees |
2
|
3
|
2 |
Chg. No. of employees % |
7%
|
12%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.